Yüklüyor......

Novel Immunotherapies for Multiple Myeloma

PURPOSE OF REVIEW: The treatment landscape of multiple myeloma is rapidly changing; however, despite improvement in patients’ survival, it still remains a largely incurable disease. One hallmark of myeloma is substantial immune dysfunction leading to an increased infection rate and the inability of...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Curr Hematol Malig Rep
Asıl Yazarlar: D’Agostino, Mattia, Boccadoro, Mario, Smith, Eric L.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2017
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5693669/
https://ncbi.nlm.nih.gov/pubmed/28819882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11899-017-0397-7
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!